SF3786
Epilepsy-related prescription drugs and medical supplies cost sharing limitation provision
Legislative Session 94 (2025-2026)
Related bill: HF3652
AI Generated Summary
Purpose
- The bill aims to limit cost-sharing (copayments and coinsurance) for epilepsy-related prescription drugs and medical supplies, by amending Minnesota Statutes 2024 section 62Q.481 subdivision 2.
Main Provisions
- Section amendment: Changes Minnesota Statutes 2024 section 62Q.481 subdivision 2.
- Definitions introduced:
- Chronic disease: includes diabetes, asthma, epilepsy, and allergies that require the use of epinephrine autoinjectors.
- Costsharing: defined as copayments and coinsurance.
- Related medical supplies: includes syringes, insulin pens, insulin pumps, test strips, glucometers, continuous glucose monitors, epinephrine autoinjectors, asthma inhalers, and other medical supply items necessary to effectively treat a chronic disease or to administer a prescription drug for a chronic disease.
- Purpose tied to cost-sharing limits: The definitions and wording are set up to establish or clarify limits on out-of-pocket costs for epilepsy-related prescription drugs and the medical supplies used to manage epilepsy and other chronic diseases.
Significant Changes to Existing Law
- Adds explicit definitions to clarify what counts as a chronic disease and what counts as related medical supplies for the purposes of cost-sharing rules.
- Applies cost-sharing limitations to epilepsy-related prescription drugs and related medical supplies, with broader reference to chronic diseases through the defined terms (e.g., chronic disease, related medical supplies).
Potential Impact
- May reduce out-of-pocket costs for individuals purchasing epilepsy-related medications and the listed related supplies.
- Provides clearer criteria for what counts as covered under cost-sharing limits, potentially affecting insurers and patients who use these drugs and supplies.
Relevant Terms
- cost-sharing
- copayments
- coinsurance
- epilepsy
- epilepsy-related prescription drugs
- chronic disease
- diabetes
- asthma
- allergies
- epinephrine autoinjectors
- related medical supplies
- syringes
- insulin pens
- insulin pumps
- test strips
- glucometers
- continuous glucose monitors
- asthma inhalers
- Minnesota Statutes 62Q.481
- Subdivision 2
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| February 23, 2026 | Senate | Action | Introduction and first reading | ||
| February 23, 2026 | Senate | Action | Referred to | Commerce and Consumer Protection | |
| Showing the 5 most recent stages. This bill has 2 stages in total. Log in to view all stages | |||||
Citations
You must be logged in to view citations.
Progress through the legislative process
In Committee
Sponsors
You must be logged in to view sponsors.